Krebs Biochemicals & Industries Share Price

65.231.76 (2.76%)

Closed
As On: 12 Jun, 2026, 03:31 PM IST
As On: 12 Jun, 2026, 03:45 PM IST

Sector: Pharmaceuticals
Industry: Pharma - Indian

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Open	64.01
High	67.89
Low	64.01
Prev Close	63.48
Volume	9,440
VWAP(₹)	65.70

Share Price	Value
Today/Current/Last	65.2364.06
Previous Day	63.4863.19

Krebs Biochem Share Recommendations

No Recommendations details available for this stock.
Check out other stock recos.

News & Analysis

View all Krebs Biochem Share News & Announcements

Share Analysis

EARNINGS

FUNDAMENTAL

RELATIVE VALUATION

RISK

PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

Score on 10-point scale
Ratings by analysts
Stock performance

JOIN ET PRIME

Financials

Income (P&L)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	8.81	7.28	4.17	5.49	6.44
Total Income Growth (%)	21.08	74.37	-24.01	-14.69	-45.06
Total Expenses	9.24	8.61	8.58	9.17	13.08
Total Expenses Growth (%)	7.32	0.33	-6.36	-29.90	-26.95
EBIT	-0.43	-1.33	-4.41	-3.67	-6.64
EBIT Growth (%)	-	-	-	-	-
Profit after Tax (PAT)	-2.34	-3.13	-6.14	-5.32	-8.27
PAT Growth (%)	-	-	-	-	-
EBIT Margin (%)	-4.87	-18.32	-105.65	-66.89	-103.10
Net Profit Margin (%)	-26.55	-42.96	-147.16	-96.94	-128.42
Basic EPS (₹)	-1.09	-1.45	-2.85	-2.47	-3.83

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	25.76	44.02	50.87	52.75	60.86
Total Revenue Growth (%)	-41.49	-13.47	-3.57	-13.32	12.03
Total Expenses	42.69	70.94	70.60	77.45	105.39
Total Expenses Growth (%)	-39.83	0.49	-8.84	-26.51	27.46
Profit after Tax (PAT)	-16.93	-26.94	-19.73	-24.69	-44.53
PAT Growth (%)	-	-	-	-	-
Operating Profit Margin (%)	-41.49	-48.50	-29.82	-41.65	-65.55
Net Profit Margin (%)	-71.35	-62.19	-39.12	-47.36	-74.58
Basic EPS (₹)	-7.85	-12.49	-9.16	-11.30	-20.81

All figures in Rs Cr, unless mentioned otherwise

Insights

PAT: Troublesome Times
Company has posted a loss of Rs 2.34 cr for the 4th consecutive quarter. (Source: Standalone Financials)
Employee & Interest Expense
Company has spent 29.86% of its operating revenues towards interest expenses and 43.77% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)

View Details

Balance Sheet

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	163.25	169.04	178.17	174.98	189.81
Total Assets Growth (%)	-3.43	-5.12	1.82	-7.81	19.21
Total Liabilities	326.00	185.27	167.39	144.44	134.90
Total Liabilities Growth (%)	75.96	10.68	15.89	7.07	-33.20
Total Equity	-162.75	-146.24	-119.22	-99.46	-75.09
Total Equity Growth (%)	-	-	-	-	-
Current Ratio (x)	0.09	0.10	0.28	0.33	0.45
Total Debt to Equity (x)	-1.38	-0.56	-0.53	-0.54	-0.17
Contingent Liabilities	0.00	24.15	4.36	5.63	5.55

All figures in Rs Cr, unless mentioned otherwise

View Details

Cash Flows

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	-1.92	-7.89	2.30	-24.71	-17.22
Net Cash used in Investing Activities	-3.64	-4.97	-7.82	-12.65	-22.90
Net Cash flow from Financing Activities	5.54	12.86	5.56	37.34	39.51
Net Cash Flow	-0.01	0.00	0.05	-0.01	-0.61
Closing Cash & Cash Equivalent	0.13	0.14	0.14	0.09	0.10
Closing Cash & Cash Equivalent Growth (%)	-8.83	3.06	60.14	-14.71	-85.84
Total Debt/ CFO (x)	-117.07	-10.42	27.53	-2.15	-0.75

All figures in Rs Cr, unless mentioned otherwise

Insights

Decrease in Cash from Investing
Company has used Rs 3.64 cr for investing activities which is an YoY decrease of 26.84%. (Source: Standalone Financials)

View Details

Ratios

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	0.00	0.00	0.00	0.00	0.00
Return on Capital Employed (%)	-19.62	-32.07	-12.92	-17.25	-35.02
Return on Assets (%)	-10.37	-15.93	-11.07	-14.11	-23.45
Interest Coverage Ratio (x)	-0.48	-2.42	-1.76	-5.10	-6.09
Asset Turnover Ratio (x)	0.14	0.25	0.29	0.29	0.34
Price to Earnings (x)	-5.10	-5.35	-6.67	-4.93	-6.94
Price to Book (x)	-0.53	-0.98	-1.10	-1.22	-4.12
EV/EBITDA (x)	-90.82	-24.86	-39.27	-20.10	-13.76
EBITDA Margin (%)	-14.42	-33.06	-16.40	-29.07	-55.00

Found Financials useful?

5 Days	14 Days	28 Days
-	-	-

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Krebs Biochem	-8.31	-0.86	0.00	-19.62	-10.37	-21.07	-41.49	-71.35	-7.85	0.09	-1.38	-117.07
Bafna Pharma	35.26	7.65	0.00	-3.29	-34.67	9.31	-4.20	-57.54	-15.52	2.11	-0.71	-0.09
Aarey Drugs	48.81	1.47	2.63	6.84	1.33	4.25	2.20	0.84	1.39	1.81	0.33	4.93
Natural Capsule	-7.00	0.69	-7.70	-5.82	-4.02	2.96	-9.06	-13.17	-23.84	1.03	0.52	10.47
Alpa Labs	10.27	0.79	7.58	8.94	5.83	5.85	16.02	13.35	6.71	4.01	0.01	0.24
Add More

Annual Ratios (%)

Choose from Peers

Bal Pharma
Par Drugs & Chemical
Vaishali Pharma
Biofil Chem
Mangalam Drugs

Choose from Stocks

Stock Performance

CHART
TABLE

1D
1W
1M
3M
6M
1Y
5Y

Choose from Peers
Choose from Stocks

NAME	1D	1W	1M	3M	1Y	3Y	5Y
Krebs Biochem Stock Performance	2.76	15.33	6.07	11.31	-12.33	0.59	-49.45
Bafna Pharma Stock Performance	-5.00	21.74	21.25	46.74	122.80	84.04	20.68
Aarey Drugs Stock Performance	2.30	-14.73	-11.70	-0.85	46.14	178.04	0.00
Natural Capsule Stock Performance	1.57	0.07	-2.93	-1.30	-21.57	0.00	0.00
Alpa Labs Stock Performance	3.90	2.18	1.31	4.15	-34.88	18.52	23.35
Add More

Category	No. of Shares	Percentage
Promoters	1,56,84,134	72.74 %
Pledge	0	0.00 %
FII	1,06,822	0.50 %
Others	57,69,630	26.76 %

Category	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Promoters	72.74	72.74	72.74	72.74
Pledge	0.00	0.00	0.00	0.00
FII	0.50	0.50	0.50	0.50
DII	0.00	0.00	0.00	0.00
Mutual Funds	0.00	0.00	0.00	0.00
Others	26.76	26.76	26.76	26.76

Mutual Funds Ownership

No Data Available

Corporate Actions

Recent
Board Meeting
Audited Results
May 07, 2026
Board Meeting
Quarterly Results & Others
Jan 14, 2026
Board Meeting
Quarterly Results
Oct 16, 2025

Board Meetings

Announced on	Meeting on
May 07, 2026	May 21, 2026
Audited Results
Jan 14, 2026	Feb 09, 2026
Quarterly Results & Others
Oct 16, 2025	Nov 04, 2025
Quarterly Results
Jul 22, 2025	Aug 07, 2025
Quarterly Results & Others
May 07, 2025	May 20, 2025
Audited Results

Dividends
Announced on Ex-Date Dividend%
Jun 09, 2005 Sep 14, 2005 30%
May 31, 2004 Sep 21, 2004 80%
Aug 09, 2003 Sep 18, 2003 80%
Jun 28, 2002 Sep 12, 2002 75%
Mar 06, 2002 - -
Bonus
No Data Available
Splits
No Data Available
Rights
Announced on Ex-Date
Jul 30, 2018 Jan 31, 2019
Rights ratio: 21 share for every 100 held at a price of Rs 86.0
AGM/EGM Meetings
Announced on Meeting on
Aug 28, 2025 Sep 26, 2025
-
Feb 24, 2025 Mar 30, 2025
-
Aug 07, 2024 Sep 27, 2024
-
Sep 12, 2023 Sep 27, 2023
A.G.M.
Feb 13, 2023 Mar 18, 2023
-

Announced on	Ex-Date	Dividend%
Jun 09, 2005	Sep 14, 2005	30%
May 31, 2004	Sep 21, 2004	80%
Aug 09, 2003	Sep 18, 2003	80%
Jun 28, 2002	Sep 12, 2002	75%
Mar 06, 2002	-	-

Announced on	Ex-Date
Jul 30, 2018	Jan 31, 2019
Rights ratio: 21 share for every 100 held at a price of Rs 86.0

Announced on	Meeting on
Aug 28, 2025	Sep 26, 2025
-
Feb 24, 2025	Mar 30, 2025
-
Aug 07, 2024	Sep 27, 2024
-
Sep 12, 2023	Sep 27, 2023
A.G.M.
Feb 13, 2023	Mar 18, 2023
-

About Krebs Biochem

Krebs Biochemicals & Industries Ltd., incorporated in the year 1991, is a Small Cap company (having a market cap of Rs 140.64 Crore) operating in Pharmaceuticals sector.

Krebs Biochemicals & Industries Ltd. key Products/Revenue Segments include Sale of services, Pharmaceuticals for the year ending 31-Mar-2025.

For the quarter ended 31-03-2026, the company has reported a Standalone Total Income of Rs 8.81 Crore, up 21.08 % from last quarter Total Income of Rs 7.28 Crore and up 36.88 % from last year same quarter Total Income of Rs 6.44 Crore. Company has reported net profit after tax of Rs -2.34 Crore in latest quarter.

The company’s top management includes Dr.R T Ravi, Mr.Manish Kumar Jain, Mr.Avinash Ravi, Mr.P K Bhattacharyya, Ms.Dipti Shah, Mr.P M Kathariya, Mr.Satya Prakash Chigurupati, Mr.Sumanth Karlapudi, Mr.Ritesh Jain, Mr.Rakesh R Kalbate. Company has Pavuluri & Co. as its auditors. As on 31-03-2026, the company has a total of 2.16 Crore shares outstanding.

Krebs Biochem Share Price Today is Rs. 65.23. On previous day, the Krebs Biochem Share Price (NSE) closed at Rs. 66.01, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 72.74% of the stake in Krebs Biochem shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of Krebs Biochem stocks was 0.5% as compared to 0.5% in Dec 2025 with decrease of 0.0%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 0.0% as compared to 0.0% in Dec 2025 with null of 0.0%. Out of the total DII holdings in Krebs Biochem shares 0.0% was held by mutual funds. The rest including public held is 0.0%. Krebs Biochem stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Krebs Biochem Dividend: Ever since 1991, Krebs Biochem dividends has been paid out around 9 times. As on 12 Jun, 2026, 03:31 PM IST, The overall dividend yield for Krebs Biochem stands at 0.0%. The last dividend paid was on null (Rs. null). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. -7.85.

Krebs Biochem Bonus: The most recent bonus issue had been in year null around 0 years ago at 0 : 0 ratio. The first bonus issue was announced in null.

Stock Forecast:
After showing 8.81 Cr. of sales and 21.08% of quarterly net profit, there have been multiple ups and downs in the Krebs Biochem stock prices in the past few weeks. For example, Krebs Biochem stock price on 4th of June 2026 was around Rs. 65.54. Krebs Biochem share price now stands at an average of Rs. 65.23. Judging by last week's performance, stock is in up trend.

Krebs Biochem has a median target price of Rs. 0.0 in 12 months by 0 analysts. They have provided a high estimate of Rs. 0.0 and low estimate of Rs. 0.0 for Krebs Biochem share.

Historical Prices and Performance:
Krebs Biochem, incorporated in 1991 is a Small Cap company (with a market cap of Rs. 136.87) operating in Pharmaceuticals sector.
The Return of Equity (ROE) in last five financial years given by Krebs Biochem stock was 0.0%, 0.0%, 0.0%, 0.0% and 0.0% respectively.
The Krebs Biochem share gave a 3 year return of -8.33% as compared to Nifty 50 which gave a return of 24.77%.
Krebs Biochem announced 0.0% final dividend on null.

Key Metrics:
PE Ratio of Krebs Biochem is -8.4
Prices/Sales Ratio of Krebs Biochem is 3.64
Price/Book Ratio of Krebs Biochem is -0.87

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For Krebs Biochem, major competitors and peers include Bafna Pharma, Aarey Drugs, Natural Capsule and Alpa Labs. As of Dec 2025, the dividend yield of Krebs Biochem stands at 0.0% while Bafna Pharma, Aarey Drugs, Natural Capsule and Alpa Labs stand at 0.0%, 0.0%, 0.0% and 0.0% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at -8.4 and -0.87 respectively.

Leadership of Krebs Biochem :
Ritesh Jain is Chief Financial Officer
Rakesh R Kalbate is Co. Secretary & Compl. Officer
R T Ravi is Chairman & Non-Exe.Director
Manish Kumar Jain is Managing Director & CEO
P K Bhattacharyya is Non Executive Director
Avinash Ravi is Non Executive Director
P M Kathariya is Independent Director
Dipti Shah is Independent Director
Satya Prakash Chigurupati is Independent Director
Sumanth Karlapudi is Independent Director

Industry

Pharma - Indian

Key Indices Listed On

-

Address

Kothapalli Village,Kasimkota Mandal,Anakapalli Dist., Andhra Pradesh - 531031

Contact

investors@krebsbiochem.com

www.krebsbiochem.com

PE Ratio(x)	-8.31
EPS - TTM(₹)	-7.85
MCap(₹ Cr.)	140.64
MCap Rank	109
PB Ratio(x)	-0.87
Div Yield(%)	-
Face Value(₹)	10.00
52W High(₹)	104.00
52W Low(₹)	38.33
MCap/Sales	3.64
Beta(1 Month)	-
BV/Share(₹)	-75.49

PE Ratio(x)	-8.16
EPS - TTM(₹)	-7.85
MCap(₹ Cr.)	138.12
MCap Rank	132
PB Ratio(x)	-0.83
Div Yield(%)	-
Face Value(₹)	10.00
52W High(₹)	103.00
52W Low(₹)	38.52
MCap/Sales	3.64
Beta(1 Month)	0.71
BV/Share(₹)	-75.49

1 Day	2.76%
1 Month	10.77%
3 Months	21.43%
1 Year	-27.53%
3 Years	-14.34%
5 Years	-47.5%

1 Day	1.37%
1 Month	10.73%
3 Months	20.64%
1 Year	-28.32%
3 Years	-17.2%
5 Years	-48.5%

R1	-	Pivot -	S1	-
R2	-		S2	-
R3	-		S3	-

Krebs Biochemicals & Industries Share Price

Key Metrics

Krebs Biochem share price insights

Krebs Biochem Share Price Returns

Krebs Biochem Share Recommendations

News & Analysis

Share Analysis

Unlock Stock Score, Analyst' Ratings & Recommendations

Financials

Technicals

Peer Comparison

Shareholding Pattern

Mutual Funds Ownership

Krebs Biochem Top Searches

Corporate Actions

About Krebs Biochem

Executive Leadership

Auditors

FAQs about Krebs Biochem share

Top Gainers

Top Losers

Equity Quick Links

More from Markets

Trending in Markets

Browse Companies

Popular Categories

Hot on Web

In Case you missed it

Top Searched Companies

Latest News